berg-life.com Listed by lockbit3 Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

On July 18, 2023, the organisation behind berg-life.com was listed by the ransomware group known as lockbit3. Public reporting states that internal files were exfiltrated in a ransomware attack. The number of people affected remains unknown, and further operational details have not been disclosed.

The listing matters because berg-life.com is described as a specialised pharmaceutical manufacturer. Any unauthorised access to internal material from such an organisation can carry consequences for business continuity, regulatory standing, and the privacy of anyone whose information may have been held in those systems.

What happened

According to available public information, berg-life.com appeared on a lockbit3 leak site on or around July 18, 2023. The reported summary characterises the incident as a ransomware attack in which internal files were allegedly exfiltrated. No confirmed figure has been published for the volume of data taken, the precise date the intrusion began, or the initial access method. The number of individuals affected is listed as unknown. Beyond the claim that internal files left the organisation’s control, specific file names, system names, or ransom demands tied to this incident have not been made public in the material provided.

As with other ransomware listings, the appearance of a victim name on a criminal leak site constitutes a claim by the group. Independent confirmation of every asserted detail is not always immediate, and organisations sometimes contest or clarify such claims after the fact. At present, the core publicly reported elements are the listing date, the attribution to lockbit3, and the description of internal-file exfiltration.

Inside lockbit3

Lockbit3 is a well-documented ransomware operation that has appeared in numerous public incident reports over recent years. Groups operating under the LockBit banner have typically used a double-extortion model: encrypting systems to disrupt operations while also copying data and threatening to publish it if a ransom is not paid. Affiliates often gain initial access through stolen credentials, exploited vulnerabilities, or phishing, then move laterally before deploying ransomware and exfiltration tools. The “3” designation refers to a later iteration of the group’s ransomware and leak-site infrastructure, which has been observed listing organisations across many countries and sectors.

Public reporting on LockBit activity has frequently noted high-volume targeting, automated negotiation portals, and the publication of sample files or full archives when victims do not pay. None of that general pattern should be read as confirmed proof of every step taken against berg-life.com specifically. For this incident, the established public fact is the group’s claim, via its listing, that it conducted a ransomware attack involving exfiltration of internal files. Additional technical claims unique to this victim have not been supplied in the source material.

berg-life.com and its sector

Public description of the organisation states that it is a leader in the manufacture of aerosol drugs in Tunisia and the only laboratory in Africa and the Middle East that masters newer HFA-propellant technology for environmentally considerate pharmaceutical applications. In practical terms, this places berg-life.com in the specialised pharmaceutical manufacturing sector, where production, quality control, regulatory documentation, and supply-chain coordination are central activities.

Organisations of this type commonly maintain detailed internal records: formulation and process data, batch and quality records, supplier and distributor information, employee and contractor details, and correspondence with regulators or commercial partners. A breach affecting such an entity is consequential not only because of potential personal data exposure but also because disruption or leakage can affect medicine supply, intellectual property, and compliance obligations in a tightly regulated industry. The geographic and technical specialisation noted in public descriptions underscores why the incident draws attention beyond a generic corporate ransomware notice.

What was likely exposed

The facts name the exposed material as internal files exfiltrated in a ransomware attack. No further breakdown—such as whether the files included human-resources records, customer or patient-related data, financial documents, manufacturing specifications, or email archives—has been disclosed in the provided information. The count of affected individuals is unknown.

Pharmaceutical manufacturers typically hold a mix of operational, commercial, and personal data. That general pattern does not establish what was taken here. Exact contents remain unconfirmed. Readers should treat any assertion about specific categories of personal or proprietary data as speculative unless and until the organisation or a competent authority publishes a verified inventory.

What's at stake

For individuals whose information may have been among the internal files, risks can include unwanted contact, phishing that references real organisational details, or misuse of identity data if such records were present. Because the affected population size and data types are unconfirmed, the concrete exposure for any single person cannot be stated with certainty.

For the organisation, stakes include operational disruption from encryption or system rebuilds, potential regulatory scrutiny common to pharmaceutical environments, commercial harm if proprietary process information was copied, and reputational damage associated with a public ransomware listing. Partners, suppliers, and healthcare customers may also face secondary risk if shared commercial or logistical data was involved. None of these outcomes is guaranteed by a listing alone; they represent the realistic range of consequences observed in comparable incidents.

What to do if you're exposed

If you have a past or present relationship with berg-life.com—as an employee, contractor, supplier, or other correspondent—monitor accounts and communications for unusual activity. Prefer official channels when verifying any message that claims to relate to the incident. Consider placing appropriate fraud alerts with relevant financial institutions if you believe identity data could have been involved, and retain records of any suspicious contact.

Because Reported Details on this claimed breach remain limited, checking whether your email address has already appeared in other known breach datasets can provide an additional early signal. Readers can run a free exposure scan of their email to see whether their information has surfaced in compiled breach data, then take follow-up steps such as password changes and enabling multi-factor authentication on important accounts. Stay alert for official notices from the organisation itself, which remain the primary source for victim-specific guidance when they are issued.

AICompiled with AI assistance from public sources and published under our editorial standards.